GleamWall
中文EN

TLSI TriSalus Life Sciences, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1826667 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY15.4%
TTM net income YoY33.7%
TTM EPS YoY80.7%
Revenue 3-yr CAGR42.5%
Net income 3-yr CAGR—

Margins

Gross margin86.5%
Operating margin-63.0%
Net margin-56.6%
FCF margin-53.3%
EBITDA margin-61.8%

Returns

ROE—
ROA-55.8%
ROIC (approx.)—
Asset turnover0.99x

Leverage & solvency

Liabilities / assets98.8%
Debt / equity47.60x
Current ratio4.22x
Interest coverage-4.92x

Cash quality & payout

Operating cash flow / net income0.93x
Accruals ratio-4.0%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$45.15M$29.43M
Cost of revenue$6.96M$4.10M
Gross profit$38.19M$25.33M
R&D expense$14.96M$17.69M
SG&A expense$21.46M$17.97M
Operating income-$26.95M-$36.16M
Interest expense$5.54M$3.09M
Pretax income-$39.22M-$30.04M
Income tax$7,000$6,000
Net income-$39.23M-$30.05M
EBITDA-$26.32M-$35.42M
EPS (basic)-1.84-1.31
EPS (diluted)-1.84-1.31
Weighted avg. shares (diluted)37.90M25.33M
Balance sheet
Cash & equivalents$20.44M$8.88M
Receivables$6.56M$5.09M
Inventory$3.08M$4.05M
Current assets$32.24M$20.67M
PP&E, net$1.81M$1.67M
Total assets$35.33M$23.97M
Current liabilities$11.50M$10.23M
Long-term debt$33.05M$22.08M
Total debt$33.05M$22.08M
Total liabilities$69.19M$49.87M
Shareholders' equity-$33.86M-$25.89M
Net debt$12.61M$13.21M
Shares outstanding50.00M31.28M
Cash flow statement
Operating cash flow-$18.01M-$40.84M
Capital expenditure$918,000$345,000
Free cash flow-$18.93M-$41.19M
Investing cash flow-$838,000-$345,000
Financing cash flow$30.76M$37.94M
Depreciation & amortization$626,000$744,000
Stock-based compensation$9.13M$5.44M

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.